Article Information
History
- October 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Martin Roesslera,*,
- Falko Tescha,
- Manuel Batramb,
- Josephine Jacobc,
- Friedrich Loserd,
- Oliver Weidingere,
- Danny Wendef,
- Annika Viviritoc,
- Nicole Toepfnerg,
- Martin Seiferta,
- Oliver Nagelc,
- Christina Königd,
- Roland Jucknewitze,
- Jakob Peter Armanng,
- Reinhard Bernerg,
- Marina Treskova-Schwarzbachh,
- Dagmar Hertlef,
- Stefan Scholzh,
- Stefan Sterne,
- Pedro Ballesterosf,
- Stefan Baßleri,
- Barbara Berteled,
- Uwe Repschlägerf,
- Nico Richterj,
- Cordula Riedererj,
- Franziska Sobikj,
- Anja Schramme,
- Claudia Schultef,
- Lothar Wielerh,
- Jochen Walkerc,
- Christa Scheidt-Naveh and
- Jochen Schmitta
- aCenter for Evidence-Based Healthcare (ZEGV), University Hospital Carl Gustav Carus and Carl Gustav Carus Faculty of Medicine, TU Dresden, Dresden, Germany
- bVandage GmbH, Bielefeld, Germany and Faculty for Business Administration and Economics, Bielefeld University, Bielefeld, Germany
- cInGef - Institute for Applied Health Research Berlin, Berlin, Germany
- dTechniker Krankenkasse, Hamburg, Germany
- eAOK Bayern - Die Gesundheitskasse, Regensburg, Germany
- fBARMER Institut für Gesundheitssystemforschung (bifg), Berlin, Germany
- gDepartment of Pediatrics, University Hospital Carl Gustav Carus and Carl Gustav Carus Faculty of Medicine, TU Dresden, Dresden, Germany
- hRobert Koch-Institut, Berlin, Germany
- iAOK PLUS, Dresden, Germany
- jDAK-Gesundheit, Hamburg, Germany
- ↵*Corresponding author: Martin Roessler, Center for Evidence-Based Healthcare (ZEGV), University Hospital Carl Gustav Carus and Carl Gustav Carus Faculty of Medicine, TU Dresden, Fetscherstr. 74, 01307 Dresden, Germany. email: correspondence.zegv{at}ukdd.de
Posted October 22, 2021.
Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19
